In this expert Q&A, Margaret A. Lampe, RN, MsC, discusses the elimination of perinatal HIV transmission, elimination goals set out by the CDC, next steps for research, and more.
In part 3 of this 3-part episode, Jeffrey Kwong, DNP, MPH, ANP-BC, discusses the benefits of HIV pre-exposure prophylaxis (PrEP) for women in preventing HIV, strategies for eliminating HIV globally,...
In part 2 of this 3-part episode, Jeffrey Kwong, DNP, MPH, ANP-BC, talks about how HIV pre-exposure prophylaxis (PrEP) has evolved over the years since becoming available for use in 2012 and the future of...
In part 1 of this 3-part series, Dr Jeffrey Kwong, DNP, MPH, ANP-BC, talks about the barriers patients may have to HIV Pre-exposure Prophylaxis (HIV PrEP)and what clinicians need to know when talking to...
In this podcast, Anne Teitelman, PhD, discusses how the human papillomavirus vaccination rate among adolescents falls short of national goals, as well as her and her colleagues intention to promote...
The incidence of sexually transmitted infections has increased significantly among individuals with HIV. Carole Khaw, MD, from the Royal Adelaide Hospital answers our questions about proactively managing...
Casper D.J. den Heijer, MD, answered our questions about his latest research on how Chlamydia trachomatis infection affects the risk of pelvic inflammatory disease, ectopic pregnancy, and infertility in...
Jason J. Ong, PhD, MBBS, from the London School of Hygiene and Tropical Medicine, answers our questions about his team’s research on STI prevalence and incidence among new and persistent users of...
Douglas K. Owens, MD, MS, from Stanford University, is the chair of the US Preventive Services Task Force. In this commentary, he writes about the Task Force’s latest guidelines on HIV screening and PrEP...
